Author:
Chollet P.,Bensmaïne M.A.,Brienza S.,Deloche C.,Curé H.,Caillet H.,Cvitkovic E.
Reference33 articles.
1. Ten years follow-up of patients receiving cisplatin, doxorubicin and cyclophosphamide (PAC) chemotherapy for stage III and IV advanced ovarian carcinima;Sutton;J Clin Oncol,1989
2. Second-line chemotherapy of stage III—IV ovarian carcinoma. A randomized comparison of melphalan to melphalan and hexamethylmelamine in patients with persistent disease after doxorubicin and cisplatin;Pater;Cancer Treat Rep,1987
3. Ovarian cancer. Chemotherapy of ovarian cancer;Ozols;Semin Oncol,1991
4. Second-line platinum therapy with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991
5. Responses to salvage chemotherapy in ovarian cancer A critical need for precise definitions of the treated population;Markman;J Clin Oncol,1992
Cited by
103 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献